Washington Trust Advisors’s DexCom DXCM Stock Holding History

Washington Trust Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Buy	+104	New	+$6.93K	﹤0.01%	546
2024 Q1	–	Sell	-353	Closed	-$43.8K	–	664
2023 Q4	$43.8K	Buy	353 +193	+121%	+$19.7K	﹤0.01%	327
2023 Q3	$14.9K	Buy	+160	New	+$18K	﹤0.01%	418
2023 Q2	–	Sell	-204	Closed	-$23.7K	–	692
2023 Q1	$23.7K	Sell	204 -24	-11%	-$2.69K	﹤0.01%	394
2022 Q4	$25.8K	Hold	228	–	–	﹤0.01%	387
2022 Q3	$18K	Hold	228	–	–	﹤0.01%	531
2022 Q2	$17K	Buy	228 +48	+27%	+$4.38K	﹤0.01%	561
2022 Q1	$23K	Sell	180 -516	-74%	-$56.4K	﹤0.01%	582
2021 Q4	$93K	Buy	+696	New	+$100K	0.01%	374

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Washington Trust Advisors's DXCM Position: Q2 2026 in Review

Washington Trust Advisors opened a new position in DexCom (DXCM) in Q2 2026: 104 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #546 among its holdings. This is a return to the name: Washington Trust Advisors previously reported a position in DXCM as recently as Q4 2023.

Washington Trust Advisors first reported a position in DXCM in Q4 2021 and has held it in 9 quarters since. The position peaked at $93K in Q4 2021. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Washington Trust Advisors held 104 shares of DexCom worth $7K as of Q2 2026.
DexCom was a new Washington Trust Advisors position in Q2 2026.
DexCom made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #546 holding.
Washington Trust Advisors first reported a position in DexCom in Q4 2021 and has held it in 9 quarters since.
Washington Trust Advisors's DexCom position peaked at $93K in Q4 2021.
976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.